Medicine & Life Sciences
Macular Degeneration
100%
Ranibizumab
93%
Vascular Endothelial Growth Factor A
82%
Bevacizumab
78%
pegaptanib
73%
Visual Acuity
55%
Ocular Vision
32%
Confidence Intervals
30%
Eye
23%
Odds Ratio
20%
Randomized Controlled Trials
17%
Choroidal Neovascularization
15%
Injections
14%
Photochemotherapy
13%
Research Personnel
13%
Registries
10%
Clinical Trials
8%
Quality of Life
8%
Endophthalmitis
7%
South America
7%
Intravitreal Injections
7%
Therapeutics
7%
Control Groups
6%
North America
6%
Intraocular Pressure
6%
Sample Size
5%
Patient Selection
5%
MEDLINE
5%
Language
5%
Economics
4%
Data Analysis
4%
Placebos
4%
Costs and Cost Analysis
3%
Databases
3%
Inflammation
3%
Blood Vessels
3%
Safety
3%
Growth
3%
Health
3%
Incidence
3%
Pharmaceutical Preparations
2%